Elekta is committed to the development of cancer care. The company offers ongoing professional education awards and also encourages the adoption of standards to support the interoperability of multi-component systems. Learn more about our current programs summarized below.
Elekta can support investigator initiated Research and Development Agreement Projects via a number of mechanisms that include the provision of research funds, information, access to research hardware and/or software, and access to other Elekta resources. In exchange, Elekta expects to benefit in the form of information, access to intellectual property and research results that are the products of your work.
Elekta has a long and rich tradition of supporting investigator initiated research that leads to advances in technology and clinical care. We depend on close collaborative relationships with investigators who are themselves leaders in their respective fields. These relationships and the results of our joint research efforts are among the keys to our success and leadership in our industry.
为了保持最高标准,我们制定了通过研究申请指导申请人的过程。该过程旨在导致互利的明确定义和高质量的研究计划。
Elekta’s Research Collaborations Program acts in accordance with international and US Federal regulations that govern research funding provided by health care manufacturers to health care providers. The Program complies with theElekta Code of Conduct,医学影像和技术联盟(MITA)与医疗保健专业人士的互动界规规范,制药商的合规计划指导从美国检查员办公室,美国联邦和美国联邦State Sunshine Reporting of Payments to Physicians.
Elekta can support investigator initiated Research and Development Agreement Projects via various mechanisms that include:
Your work will in turn benefit Elekta in the form of information, access to intellectual property, research results and the like.
要申请研究资助,请填写申请表。要申请申请表,请发送电子邮件给您的请求Scientific.Research@elekta.com.
This application has been adapted from U.S. National Institution of Health applications that are likely familiar to you. Applications should be focused, achievable and not overly ambitious. Please note that Elekta places a high value on having clearly defined goals and tasks, meeting specific milestones and providing associated deliverables. It should be made clear how these goals would be met and the tasks achieved. Please also limit your requests to that which would be required to complete the project.
The Elekta Research Grant Program is intended to support clinical and technological research activities that will advance knowledge and promote innovation. Research proposals shall be expected to demonstrate strong potential for clinical innovation, technological innovation or commercialization, relating to advancements in Elekta products and clinical solutions including Stereotactic Body Radiotherapy (SBRT).
Elekta’s research committee meets on a regular basis to review grant applications. We make our best effort to respond to you within 8-12 weeks of receipt of a completed application. If approved, we will work with you to develop a formal Research Agreement between Elekta and your Institution. The project only begins after the Research Agreement has been executed. No commitments should be made by the researcher in anticipation of this event.
为了优化直接研究贡献与研究的平衡,Elekta建立了一项公司政策,以支持最高资金水平,以实现25%的间接费用。这是一致的,在某些情况下,超过行业范围的资金水平以及基本上没有基于行业的基本上更大的研究支持计划的间接融资水平。
获取更多资讯,请联系:Scientific.Research@elekta.com.
Elekta特别强调研究进展使用基于线性加速器的立体定向体放射治疗(SRT)和立体定向放射治疗(SRT)。强烈鼓励与使用线性加速器的SBRT相关的应用程序,并将优先考虑。
Elekta特别强调研究进展使用基于线性加速器的立体定向体放射治疗(SRT)和立体定向放射治疗(SRT)。强烈鼓励与使用线性加速器的SBRT相关的应用程序,并将优先考虑。
在过去的二十年中,立体定位体放射治疗的发展已经在显着发展。如今,SBRT在许多解剖部位肿瘤治疗常用。坚定的信念,即该技术具有改善成果的重要潜力,降低成本部分是推动这些努力。然而,技术和结果成果差异很大,仍有很多学习。
因此,Elekta正在促进努力推进对SBRT的理解,特别是与使用线性加速器技术涉及其交付。我们的近期研究和开发工作的大量比例将在SBRT上将,我们邀请我们的研究合作伙伴参加这些活动。我们的授予机制旨在促进这些努力,并鼓励指导这些目标的应用程序。
Please refer to the 'Research Grants' section above for general information about research grants and compliance with international and US regulations. You will also find information about the grant evaluation process and the Elekta policy on indirect costs.
For further information or to request a grant application form, please email your request toScientific.Research@elekta.com.
ELEKTA的OpenRT认证计划建立了合规性,验证,部署和支持标准,以支持多组分系统的互操作性,并提高护理质量。
在Elekta,我们认为,标准合规和系统范围的功能是开发综合工具以提高整体过程效率的重要方面。ELEKTA的OpenRT认证计划建立了合规性,验证,部署和支持标准,以支持多组分系统的互操作性,并提高护理质量。通过OpenRT认证,客户可以购买治疗计划系统和EMR / V&R系统,而无需担心该系统将共同努力。
该程序可确保治疗计划系统,Elekta电子医疗记录(EMR)和线性加速器之间的连接,要求供应商转移有效管理治疗计划,设置和交付所需的所有数据。
With OpenRT Certification, technical support is available in a single phone call. Customers may contact either Elekta or their treatment planning vendor to resolve any problems that arise.
Elekta would like to acknowledge罗唆和Philipsin their efforts to join us in establishing a program to ensure interoperability across multiple systems.
Please contact the program administrator,莱昂Tomczyk., for additional information.
The mission of the Elekta Software Oncology Data Alliance (ODA) is to improve patient cancer care through the analysis of aggregate oncology data.
肿瘤学数据联盟(ODA)的目标是通过分析聚集肿瘤学数据来改善患者癌症护理。188棋牌捕鱼此数据联盟将是唯一的:
As always, Elekta will apply and set standards for quality data and will incorporate feedback from current customers to make this a unique and valuable evaluation and research tool for oncology treatment centers. Benchmark reports can help our current customers to maximize their investment in Elekta software. With a team focusing on the ODA, there will be a dedicated Elekta employee available to assist with quality assurance and data quality of the ODA at individual customer sites as well as the database as a whole. These benchmarking reports will allow participating facilities to:
每个参与者都进入了两年的可再生术语,并被要求完成最低的数据集要求,以保持高标准的质量。此外,参与设施将:
For more program information, contactDave Eggert
Elekta Software’s Registrar of the Year program honors outstanding Elekta Software cancer registrars who have made valuable contributions to the success of the registry and have expanded their contributions to the broader facility and community.
Elekta sponsors this award which is presented annually at the AANS meeting. Started in 2009, the award is for the best paper on stereotactic radiosurgery as related to brain tumors.
每年elekta赞助了与肿瘤部分AAN和CNS的脑肿瘤相关的最佳纸张上最佳纸张奖。获奖者在AANS年会上呈现。
Elekta Software registry customers regularly contribute data to Elekta Software’s National Oncology DataBase™ (NODB) through quality-checked submissions directly from their registry software. In return, Elekta Software provides primary site-specific aggregate data reports to contributors via the Internet. Elekta Software’s registry customers can use this information to generate annual reports, internal comparative reviews, and much more.
Frequently, Elekta is asked about the proper way to cite the use our products in the professional literature, in professional meeting posters or in oral presentations. Because Elekta has grown as an entity both organically and by acquisition of leading industry corporations and their products, there has been considerable confusion about the proper citation language.
为了展示我们对交付Linear Accelerator用户的世界级立体定向解决管解决方案的承诺,Elekta介绍了一个旨在支持我们的协作和研究合作伙伴的计划。